Your current position :

Breakthrough in Anti-Aging: David Sinclair's Team Reveals Exciting Results of Super NMN
  • 2023-12-21
  • admin

Summary: David Sinclair's team, known for reversing aging through cell reprogramming, now shares new findings on a powerful NMN variant called MIB-626. The study, published in "The Journal of Clinical Endocrinology & Metabolism," explores MIB-626's effects on 30 participants, showing promising outcomes.

Background: NMN boosts NAD+ levels in the body, influencing various life processes. MIB-626, a more stable form of NMN, surpasses traditional NMN in performance.

Future Outlook: Apart from collaborating with the U.S. military, MIB-626 plans human trials for anti-aging, Alzheimer's, kidney issues, and ataxia.

Latest Results: In a 28-day trial with participants aged 45 and above, MIB-626 proved safe and effective:

  • No severe side effects were reported.
  • MIB-626 significantly increased NAD+ levels by 200%, impacting metabolism positively.
  • Participants experienced weight loss, improved cholesterol levels, and reduced blood pressure.

Study Insights and Challenges: Despite positive outcomes, the study faced challenges such as a smaller participant count and a short trial duration. Age and other differences between groups raised concerns.

Upcoming Trials: Metro Biotech, focusing on MIB-626, has three ongoing trials, promising more insights.

Conclusion: While improvements are needed, the study's positive results highlight MIB-626's potential. Ongoing trials offer hope for a clearer understanding. The ultimate goal is the early launch of an anti-aging drug for broader public use.



For more health advice and information about AIDEVI, please subscribe and send us an email
Sign up to know more about new product lounches,dosages, health........